![](/img/cover-not-exists.png)
The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer
Amanam, Idoroenyi, Gupta, Rohan, Mambetsariev, Isa, Salgia, RaviLanguage:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2017-0545
Date:
February, 2018
File:
PDF, 1.35 MB
english, 2018